International Journal of Molecular Medical Science, 2025, Vol.15, No.5, 224-234 http://medscipublisher.com/index.php/ijmms 2 34 Zhao H., Huang S., Wu J., Lu Y., Zou Y., Zeng H., Li C., Wang J., Zhang X., Duan S., and Liang W., 2025, Efficacy and safety of first-line PD-1/PD-L1 inhibitor in combination with CTLA-4 inhibitor in the treatment of patients with advanced non-small cell lung cancer: a systemic review and meta-analysis, Frontiers in Immunology, 16: 1515027. https://doi.org/10.3389/fimmu.2025.1515027 Zhou K., Li S., Zhao Y., and Cheng K., 2023, Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer, Frontiers in Immunology, 14: 1127071. https://doi.org/10.3389/fimmu.2023.1127071
RkJQdWJsaXNoZXIy MjQ4ODYzNA==